“Nanotechnology Based Drug Delivery System Of Rivastigmine For The Treatment Of Alzheimer’s Disease”. Journal of Pharmaceutical Negative Results, Jan. 2022, pp. 2532-41, https://doi.org/10.47750/pnr.2022.13.S01.298.